Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C

BACKGROUND: The standard of care for HCV Hepatitis is the combination of interferon (IFN) plus Ribavirin. In HIV patients the use of this combination therapy may induce drug interactions, and reduces the adherence to HAART. The aim of this study is to evaluate safety and efficacy of a 48 weeks daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Raffaele, Sacchi, Paolo, Puoti, Massimo, Ciappina, Valentina, Zocchetti, Cristina, Brunetti, Enrico, Maffezzini, Elena, Capelli, Anna, Patruno, Savino FA, Malfitano, Antonello, Filice, Gaetano
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128825/
https://www.ncbi.nlm.nih.gov/pubmed/12199910
http://dx.doi.org/10.1186/1471-2334-2-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128825/
https://www.ncbi.nlm.nih.gov/pubmed/12199910
http://dx.doi.org/10.1186/1471-2334-2-17

Ejemplares similares